Pharmaceuticals

FDA
#Drug approvals #Parkinson's #Pharmaceuticals

First live biotherapeutic approved to treat Parkinson’s disease 

The US Food and Drug Administration (FDA) has cleared investigational new drug (IND) applications for MRx0005 and MRx0029, two 4D Pharma Live Biotherapeutics (LBPs). The company expects to initiate a first-in-human Phase I clinical trial in people with Parkinson’s disease in mid-2022.  Context  Parkinson’s disease… Read More

#News

#Clinical trials #Comment #Pharmaceuticals

Do end-to-end CDMOs hold the secret to success in cell and gene therapy?

The cell and gene therapy (CGT) industry is booming, say Sergio Lainez Vicente (Senior Manager of Business Operations in the Cell & Gene Therapy / Large Molecule area) and Jaleel Shujath (Vice President of Marketing and Content), at Absorption Systems, a Pharmaron company. Around 1200 potential cell and gene… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#Drug discovery #Pharmaceuticals

Pharmaceutical executive takes the Synature Discovery reins 

Sygnature Discovery, providers of drug discovery solutions, has appointed Dr Charles Woler as Chairman.  Woler’s career Dr Woler has held multiple key roles in the sector, including CEO at Roche France, Executive Chairman for Europe at SmithKline Beecham, and CEO at Cadus Pharmaceutical in the US.   Official comments … Read More

#News #Trending News

#Drug discovery #Drug targets #Drug technology #Pharmaceuticals #Quantum computing

How quantum computing can benefit drug discovery 

Listen to this article on the DDW Podcast: Brad Loren, Matthew Marrone, and Christopher Singer, of intellectual property and technology law firm McAndrews, Held & Malloy, on quantum computing and its benefits to drug discovery.  Explaining quantum computing and its promise  Before we… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#Biologics #Biotechnology #Pharmaceuticals #Research

Sino Biological establishes new location in Texas 

Sino Biological, provider of biological research reagents and related technical contract research services, has expanded to a new location in Houston, Texas.  The company has headquarters in Beijing, China and subsidiaries in Suzhou (China), Taizhou (China), Frankfurt (Germany), and Wayne (Pennsylvania, US). The new location in Houston allows for… Read More

#News

Seed funding
#Biotechnology #Pharmaceuticals

CSL to acquire Vifor Pharma

Global biotechnology company CSL Limited has launched a public tender offer to acquire all publicly held Vifor Pharma shares.  “Vifor Pharma enhances CSL’s patient focus and ability to protect the health of those facing a range of rare and serious medical conditions. It brings an outstanding team and a leading portfolio… Read More

#News

#Bipolar #Collaboration #Drug development #Pharmaceuticals

Partnership meets an unmet need for bipolar disorder patients 

Lo.Li. Pharma International has announced a new strategic partnering plan for its new product, Deplesin, which meets an unmet need for bipolar disorder (BD) patients. The discussions are underway with the aim of increasing accessibility to this novel adjunctive agent in the treatment of BD patients, who often experience a number… Read More

#News

MicroRNA
#Biopharmaceutical #Drug development #Pharmaceuticals #Therapeutics

Regulus appoints VP of chemistry and pharmaceutical development 

Regulus Therapeutics, a biopharmaceutical company focused on the discovery and development of medicines targeting microRNAs, has appointed Mohammad Ahmadian as Vice President of Chemistry and Pharmaceutical Development.   The role  In his role, Dr. Ahmadian will assist in managing research and development of the company’s drug… Read More

#News

#Biopharma #Biotechnology #Drug innovation #Pharmaceuticals #Report #Research

Pharmaceuticals and biotech lead UK university innovation 

University technology and innovation is driving the UK’s status in pharmaceuticals and biotechnology, according to GovGrant’s University Spinouts Report 2021.  The report  According to the new report, the pharmaceuticals and biotechnology sector dominates the top ten spinout companies of the last decade, ranked by valuation. Pharma and… Read More

#News #Trends & Analysis

Human brain
#Drug development #Drug discovery #Healthcare #Neuroscience #Pharmaceuticals

NICE approves drug which treats EDS caused by narcolepsy 

Jazz Pharmaceuticals’ Sunosi (solriamfetol) has been issued a positive Final Appraisal Document (FAD) from the National Institute for Health and Care Excellence (NICE), recommending the drug for adults with excessive daytime sleepiness (EDS) caused by narcolepsy.1  When is solriamfetol needed?  Solriamfetol is recommended as an option for treating EDS… Read More

#News #Trending News

#Life sciences #Market reporting #Pharmaceuticals #Research

Horizons report finds biopharma leaders at a crossroads 

CRB has released an industry report based on survey responses from more than 500 industry leaders and with unique analysis from CRB’s life sciences subject matter experts.  What is in the report?  Warp speed delivery: Speed to market is a more significant business driver in… Read More

#News

#Covid-19 #Drug discovery #Pharmaceuticals

Newly launched antiviral nasal spray reduced Covid in ICU by 80%  

Amcyte Pharma has launched Nasitrol nasal spray for sinus irrigation in the US. In an independent clinical trial published in the peer-reviewed International Journal of General Medicine, Nasitrol reduced Covid transmission among ICU staff by nearly 80%, suggesting it could represent a safe and effective prophylaxis to prevent transmission of Covid-19.   What… Read More

#News

#Clinical trials #CRO #Pharmaceuticals #Research

Advantages of working with CROs in Central and Eastern Europe 

Discover how Central and Eastern Europe (CEE) provides an attractive environment to conduct clinical studies of any phase while partnered with a local CRO in this interview with Research Professionals’ Managing Partner, György Barta (DPharm).  Barta discusses the many benefits of conducting clinical studies in CEE as… Read More

#News

#Bioeconomics #Market reporting #Pharmaceuticals

Report: The Latin American research-based pharmaceutical industry  

Examining the role of the pharmaceutical industry in alleviating challenges is helpful to understand how people are benefiting from innovative medicines. This report examines the impact of the pharmaceutical industry in nine Latin American countries (Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Mexico, Panama, and Peru) by analysing its impact… Read More

#Market Reports #News #Trends & Analysis

#Drug development #Drug discovery #Pharmaceuticals

Doloromics appoints President and Chief R&D Officer

Doloromics has appointed Dr. Chris Flores as their new President and Chief Research and Development Officer. In this role, Dr. Flores will be responsible for leading the Doloromics portfolio of drug discovery and development programmes, two of which are scheduled to launch in early 2022, while building relationships with strategic partners and collaborators… Read More

#News